| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/21/2012 | CA2350185C Method for detecting and purifying tcd8+ lymphocyte populations, specific of peptides present in the context of hla |
| 02/21/2012 | CA2338250C Lafora's disease gene |
| 02/21/2012 | CA2322055C Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
| 02/21/2012 | CA2321934C Manganese superoxide dismutase exon 3-deleted isoforms and nucleic acid molecules encoding the isoforms |
| 02/21/2012 | CA2263835C Stimulus-inducible i (kappa)b kinase [ikk] signalsome |
| 02/21/2012 | CA2213780C Pharmaceuticals containing multipotential precursor cells from tissues containing sensory receptors |
| 02/18/2012 | CA2808265A1 Solution for extraction of rna |
| 02/16/2012 | WO2012021885A1 Three-dimensional tissue engineering devices and uses thereof |
| 02/16/2012 | WO2012021867A2 A comprehensive methylome map of myeloid and lymphoid commitment from hematopoietic progenitors |
| 02/16/2012 | WO2012021851A2 Methods and compositions for diagnosing and treating lupus |
| 02/16/2012 | WO2012021803A1 Method for using ref protein as a targeted reca-dependent nuclease |
| 02/16/2012 | WO2012021802A2 Method for identifying antimicrobial compounds and determining antibiotic sensitivity |
| 02/16/2012 | WO2012021785A1 Compositions and methods comprising sequences having hydroxyphenylpyruvate dioxygenase (hppd) activity |
| 02/16/2012 | WO2012021769A1 Methods for diagnosing hypertrophic cardiomyopathy |
| 02/16/2012 | WO2012021749A1 Genotyping dna |
| 02/16/2012 | WO2012021741A2 Lateral flow assays for non-diagnostic analytes |
| 02/16/2012 | WO2012021733A2 Photodamage mitigation compounds and systems |
| 02/16/2012 | WO2012021707A2 Premature-termination-codons readthrough compounds |
| 02/16/2012 | WO2012021554A1 Cyclic di-gmp-ii riboswitches, motifs, and compounds, and methods for their use |
| 02/16/2012 | WO2012021516A2 Nanoparticle-oligonucletide hybrid structures and methods of use thereof |
| 02/16/2012 | WO2012021493A2 Compositions and methods for quantifying a nucleic acid sequence in a sample |
| 02/16/2012 | WO2012021407A2 Biomarkers for stroke |
| 02/16/2012 | WO2012021308A2 Method for retrovirus removal |
| 02/16/2012 | WO2012021106A1 Detection of dengue virus serotypes 1 to 4 |
| 02/16/2012 | WO2012021054A2 A diagnostic system for malaria |
| 02/16/2012 | WO2012020965A2 Pik3ca mutation detection method and kit using real-time pcr clamping of pna |
| 02/16/2012 | WO2012020845A1 Method of producing pancreatic hormone-producing cells |
| 02/16/2012 | WO2012020759A1 Variant reverse transcriptase |
| 02/16/2012 | WO2012020745A1 Method for measuring glycosylated hemoglobin |
| 02/16/2012 | WO2012020744A1 Method for measuring glycated hemoglobin |
| 02/16/2012 | WO2012020711A1 Microchamber array device which has electrical function and inspection object analysis method using same |
| 02/16/2012 | WO2012020679A1 Method and test piece for simultaneously typing influenza virus a and detecting oseltamivir phosphate-resistant mutation |
| 02/16/2012 | WO2012020385A1 Method for diagnosing neurodegenerative diseases |
| 02/16/2012 | WO2012020281A1 New markers for the epithelial and proliferative or mesenchymal invasive phenotype of human neoplasias |
| 02/16/2012 | WO2012020257A1 Method and system for analyzing a sample |
| 02/16/2012 | WO2012020126A1 A method for classifying an inflammatory bowel disease as a crohn's disease or as an ulcerative colitis |
| 02/16/2012 | WO2012020102A1 Methods and kits for of identifying a premature infant at risk of having or developing bronchopulmonary dysplasia |
| 02/16/2012 | WO2012020015A1 Improved method for isothermal amplification of nucleic acids |
| 02/16/2012 | WO2012019786A1 Method and kit for the diagnosis and/or prognosis of tolerance in liver transplantation |
| 02/16/2012 | WO2012019765A1 Methods and systems for tracking samples and sample combinations |
| 02/16/2012 | WO2012019436A1 Microfluidic device for cell motility screening and chemotaxis testing |
| 02/16/2012 | WO2012019323A1 Method for analyzing cell chromosome |
| 02/16/2012 | WO2012019320A1 High-throughput sequencing method for methylated dna and use thereof |
| 02/16/2012 | WO2012019300A1 Endometrial cancer biomarkers and methods of identifying and using same |
| 02/16/2012 | WO2012019235A1 Treatment and diagnosis of epigenetic disorders and conditions |
| 02/16/2012 | WO2011155833A3 Combinatorial sequence barcodes for high throughput screening |
| 02/16/2012 | WO2011154616A3 Use of abo type |
| 02/16/2012 | WO2011154553A3 Micrornas for the detection and isolation of human embryonic stem cell -derived cardiacv cell types |
| 02/16/2012 | WO2011138635A8 Capillary electrophoresis chips |
| 02/16/2012 | WO2011137368A3 Systems and methods for analyzing nucleic acid sequences |
| 02/16/2012 | WO2011126740A9 Hip1 cancer markers |
| 02/16/2012 | WO2011112880A3 Hypermethylation biomarkers for detection of head and neck squamous cell cancer |
| 02/16/2012 | WO2011102914A3 Automated polymer-synthesis system |
| 02/16/2012 | WO2011102913A3 Wicking-based reagent-solution draining in an automated system |
| 02/16/2012 | WO2011086497A3 Three-stage thermal convection apparatus and uses thereof |
| 02/16/2012 | WO2011004148A8 Methods related to a mutation in complement factor h-related protein 5 in patients with glomerulonephritis |
| 02/16/2012 | WO2010107740A8 Treatment of delta-like 1 homolog (dlk1) related diseases by inhibition of natural antisense transcript to dlk1 |
| 02/16/2012 | US20120042416 Antibody fusion-mediated plant resistance against Oomycota |
| 02/16/2012 | US20120042413 Compositions And Methods Comprising Sequences Having Hydroxyphenylpyruvate Dioxygenase (HPPD) Activity |
| 02/16/2012 | US20120042407 Corn event 5307 |
| 02/16/2012 | US20120042398 Compositions for labeling and identifying autophagosomes and methods for making and using them |
| 02/16/2012 | US20120041687 Identification, monitoring and treatment of infectious disease and characterization of inflammatory conditions related to infectious disease using gene expression profiles |
| 02/16/2012 | US20120041303 Phage antibodies to radiation-inducible neoantigens |
| 02/16/2012 | US20120041274 Cancer biomarkers |
| 02/16/2012 | US20120041176 Ucp4 |
| 02/16/2012 | US20120041082 Methods of using smad3 and jak2 genetic variants to diagnose and predict inflammatory bowel disease |
| 02/16/2012 | US20120041056 Nucleic acids specifically binding with human factor vii/viia and uses thereof |
| 02/16/2012 | US20120041053 DELIVERY OF dsRNA TO ARTHROPODS |
| 02/16/2012 | US20120041048 COMPOSITIONS AND METHODS RELATING TO miR-31 |
| 02/16/2012 | US20120041023 Small molecule activators of mitochondrial function |
| 02/16/2012 | US20120041017 Pyridocarbazole type compounds and applications thereof |
| 02/16/2012 | US20120041001 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 02/16/2012 | US20120040995 Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs |
| 02/16/2012 | US20120040976 Small molecule immunomodulators for alzheimer's disease |
| 02/16/2012 | US20120040966 Anti-viral compounds, treatment, and assay |
| 02/16/2012 | US20120040938 Glucocorticoid receptor alleles and uses thereof |
| 02/16/2012 | US20120040906 Protein targets in disease |
| 02/16/2012 | US20120040900 Compositions of and methods of using ligand dimers |
| 02/16/2012 | US20120040894 Mini-Hepcidin Peptides and Methods of Using thereof |
| 02/16/2012 | US20120040884 Methods and Reagents for Treatment and Diagnosis of Vascular Disorders and Age-Related Macular Degeneration |
| 02/16/2012 | US20120040866 High Resolution Label Free Analysis of Cellular Properties |
| 02/16/2012 | US20120040862 Method for detecting and quantifying endogenous wheat dna sequence |
| 02/16/2012 | US20120040859 Assay systems for genetic analysis |
| 02/16/2012 | US20120040858 Biomarkers for stroke |
| 02/16/2012 | US20120040857 Isolation of factors that associate directly or indirectly with chromatin |
| 02/16/2012 | US20120040855 Tissue-specific aging biomarkers |
| 02/16/2012 | US20120040854 Method for in vitro diagnosis or prognosis of testicular cancer |
| 02/16/2012 | US20120040851 miRNA TARGETS |
| 02/16/2012 | US20120040848 Molecular signature of liver tumor grade and use to evaluate prognosis and therapeutic regimen |
| 02/16/2012 | US20120040845 Advanced pathogen testing and carcass-certification methods for slaughter operations |
| 02/16/2012 | US20120040842 Gene Expression Markers for Prediction of Patient Response to Chemotherapy |
| 02/16/2012 | US20120040394 Microtumours |
| 02/16/2012 | US20120040393 Directed Differentiation of Primate Pluripotent Stem Cells Into Functional Basal Forebrain Cholinergic Neurons (BFCNs) and Medium Spiny Gabaergic Projection Neurons |
| 02/16/2012 | US20120040392 Dosimetry using sigma singlet oxygen spectroscopy |
| 02/16/2012 | US20120040391 Sepsis diagnostic test |
| 02/16/2012 | US20120040390 Method for Introducing Protein and/or Peptide Into Cell |
| 02/16/2012 | US20120040389 Method for demonstration of a molecular event in a cell by means of fluorescent marker proteins |
| 02/16/2012 | US20120040388 Cellulase-containing dish detergents |
| 02/16/2012 | US20120040387 Method and reagent for measuring mevalonic acid, 3-hydroxymethylglutaryl coenzyme a, and coenzyme a |
| 02/16/2012 | US20120040386 Fine-grained filler substances for photometric reaction films |